Latest news with #Chattopadhyay
Time of India
11-05-2025
- General
- Time of India
Flamingo with injured leg rescued, released at NRI wetland in Nerul
A nature lover and wildlife photographer, Abhijit Chattopadhyay, helped rescue a flamingo with an injured left leg from the NRI wetland in Nerul Sector 58A on Monday. His distress call led to the rescue of the migratory bird by the forester, Vikas Bairagi, who admitted it to veterinarian Dr Kartik Iyer in Vashi for treatment. However, as recommended by the vet, the bird was released at the same spot as no artificial limbs could be provided and fixed. Operation Sindoor Amid flare-up hours after thaw, officials say things will settle down with time Ceasefire on, but pressure stays: Key decisions by India against Pak that still stand 'Will work with India & Pakistan to seek solution on Kashmir': Trump The injury affected the bird's flight, as well as its ability to run and take off. Many have expressed concern over the hurdles the pink birds are facing here. You Can Also Check: Mumbai AQI | Weather in Mumbai | Bank Holidays in Mumbai | Public Holidays in Mumbai Abhijit first photographed the lone flamingo five days ago in the vast wetland while the bird was standing in one place, busy preening itself. During successive visits, hoping to spot more flamingos, he noticed on the third day that the flamingo had not moved. The bird was released at the same spot on 6 May evening after a brief stay at the hospital. The bird was trying to walk, limping, using the force of its outstretched wing with each step. On the fifth day, Chattopadhyay was convinced that the bird was in distress and shared its photograph with others. He sought the assistance of the forester, Bairagi. The bird had no claws on its left leg when sighted initially. The flamingo was solo and almost a permanent member in the first left-hand side of the water body when someone enters the NRI wetland behind the NRI complex high rises. Initially, Chattopadhyay sought help from a flamingo catcher to ensure its leg was treated properly before releasing it to its natural habitat. The image taken by Chattopadhyay clearly shows that the bird lost its left foot/claw, which is why it was limping, putting pressure on its wings to take a step forward. The bird is suffering, and bird lovers hope it survives the odds in the absence of proper medical care. Chattopadhyay said, 'I don't know what kind of accident caused the injury, but imagining its struggle to walk is unbearable. An artificial claw seems like the only solution, yet feels like a distant dream in our country. I pray the Almighty brings some relief to this brave suffering soul.' Bairagi said, 'The bird lost part of its leg to an injury, but not naturally by birth. Hence, it was released as no artificial limbs can be provided.' A number of flamingos flock to the city wetlands, giving them a pink picturesque beauty, thereby attracting wildlife photographers from across the globe. The visitors watch and take photographs. Some of these photographs have been featured and awarded in international events. A major part of the city wetlands houses the migratory birds, with their presence adjoining the Thane Creek Flamingo Sanctuary. The city wetlands now face encroachment from the builders' lobby. Meanwhile, the recent sightings of injured flamingos have once again brought into sharp focus the urgent need for a veterinary hospital in the Navi Mumbai Municipal Corporation (NMMC) area, according to local environmentalists and animal welfare activists. The NMMC concrete structure for the animal hospital at Juinagar has been ready for about four years but the facility is yet to start, NatConnect Foundation pointed out. As a result, currently, wildlife enthusiasts must either seek assistance from charitable veterinarians or travel to facilities in Thane or Mumbai. NatConnect director B N Kumar pointed out that 'we keep coming across injured birds and animals, but unfortunately there is no veterinary hospital in the NMMC area.' He recalled that during the January-May period, close to 20 flamingos died around DPS and NRI wetlands. Some of them crashed into the huge signboard built for the Nerul jetty, while others got disoriented apparently due to light pollution in the area, Kumar said. Following public protests, CIDCO ultimately dismantled the hoarding. BNHS Deputy Director Dr Rahul Khot suggested to the NMMC engineers to change the lights in patches off Palm Beach Road toward DSP School and then near the Nerul Jetty road. The shade over the bulbs should be at a 45-degree angle so that the light flows downward and not sideward, which can impact the vision of the migratory birds, Dr Khot said. A forest official said the birds could be getting hurt when they crash into fishing nets, tree branches, or wires. Or big crabs could be hurting them when the birds cross their paths. Get the latest lifestyle updates on Times of India, along with Mother's Day wishes , messages , and quotes !
Globe and Mail
02-05-2025
- Business
- Globe and Mail
Why Edgewise Therapeutics Stock Popped This Week
On Thursday, an analyst launched coverage of Edgewise Therapeutics (NASDAQ: EWTX) stock, and the market took notice in a good way. On the back of his bullish view of the company, according to data compiled by S&P Global Market Intelligence, its share price vaulted nearly 14% higher across the week. An analyst finds his inner bull with the biotech That professional was Guggenheim's Debjit Chattopadhyay, who initiated his Edgewise Therapeutics coverage with a buy recommendation, and price target of $41 per share. That's well more than double the biotech stock's most recent closing price, just shy of $17. According to reports, Chattopadhyay wrote in his inaugural research note on Edgewise that with its attractive enterprise value (EV), combined with quite a promising pipeline, the company's stock has significant upside potential. That EV currently stands at over $1 billion, the analyst pointed out, and it has not one but two promising development programs. The first is EDG-7500, a treatment targeting obstructive and nonobstructive hypertrophic cardiomyopathy, a heart disorder, and the second is Duchenne muscular dystrophy drug sevasemten. Clinical trial results should come in for both within the next year. A word of caution Given all that, Edgewise is in a better position than many other biotechs to succeed. We should always bear in mind with such companies, however, that much depends on their pipelines. If experimental drugs do well in the lab and ultimately win regulatory approval, the developer could be quite the winner on the stock market. However, the opposite is usually true if a pipeline drug flops. Should you invest $1,000 in Edgewise Therapeutics right now? Before you buy stock in Edgewise Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Edgewise Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $611,271!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $684,068!* Now, it's worth noting Stock Advisor 's total average return is889% — a market-crushing outperformance compared to162%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of April 28, 2025
Yahoo
02-05-2025
- Business
- Yahoo
Why Edgewise Therapeutics Stock Popped This Week
A researcher initiated coverage of the stock with a buy recommendation. He feels its price could reach $41 per share. On Thursday, an analyst launched coverage of Edgewise Therapeutics (NASDAQ: EWTX) stock, and the market took notice in a good way. On the back of his bullish view of the company, according to data compiled by S&P Global Market Intelligence, its share price vaulted nearly 14% higher across the week. That professional was Guggenheim's Debjit Chattopadhyay, who initiated his Edgewise Therapeutics coverage with a buy recommendation, and price target of $41 per share. That's well more than double the biotech stock's most recent closing price, just shy of $17. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » According to reports, Chattopadhyay wrote in his inaugural research note on Edgewise that with its attractive enterprise value (EV), combined with quite a promising pipeline, the company's stock has significant upside potential. That EV currently stands at over $1 billion, the analyst pointed out, and it has not one but two promising development programs. The first is EDG-7500, a treatment targeting obstructive and nonobstructive hypertrophic cardiomyopathy, a heart disorder, and the second is Duchenne muscular dystrophy drug sevasemten. Clinical trial results should come in for both within the next year. Given all that, Edgewise is in a better position than many other biotechs to succeed. We should always bear in mind with such companies, however, that much depends on their pipelines. If experimental drugs do well in the lab and ultimately win regulatory approval, the developer could be quite the winner on the stock market. However, the opposite is usually true if a pipeline drug flops. Before you buy stock in Edgewise Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Edgewise Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $611,271!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $684,068!* Now, it's worth noting Stock Advisor's total average return is 889% — a market-crushing outperformance compared to 162% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of April 28, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Edgewise Therapeutics Stock Popped This Week was originally published by The Motley Fool
India Gazette
27-04-2025
- India Gazette
Delhi: Two killed in fire incident in Rohini
ANI 27 Apr 2025, 17:51 GMT+10 New Delhi [India], April 27 (ANI): At least two people lost their lives in a fire that broke out at a jhuggi (slum) near Shri Niketan Apartment in Sector 17 of Rohini in the national capital on Sunday, police said. The bodies of the two victims have been recovered from the spot, and further search and rescue operations are currently underway. MK Chattopadhyay, Deputy Chief Fire Officer of the West Zone, stated that two children with burn injuries were recovered and they have been shifted to the hospital. He clarified that the cause of the fire is yet to be ascertained. 'We received a call at 11:55 am... As soon as we received the call, according to SOP, our ADO, AK Sharma and 4-5 fire brigades were dispatched to the site. Since the lanes here are narrow, our vehicles could not reach the site. Seeing the intensity of the fire, it was declared a Medium category fire. Now, nearly 26 vehicles are deployed here on the scene... Two children with burn injuries were recovered, and they have been shifted to the hospital... The cause of the fire is not ascertained yet; the police will investigate it,' Chattopadhyay said. Further details on the incident are awaited. Meanwhile, the national capital recorded its highest day temperature in April in the last three years on Saturday, reaching 42.1C, according to the India Meteorological Department (IMD). The Met Department has also forecast a rise in temperature in the coming days in the city. (ANI)
CBC
18-04-2025
- Entertainment
- CBC
The Sunday Magazine for April 20, 2025
This week on The Sunday Magazine with Piya Chattopadhyay: The federal election campaign enters its final stretch With two debates down and one week to go in the federal election campaign, The Economist's Rob Russo, Le Devoir's Emilie Nicolas and Real Talk's Ryan Jespersen join Chattopadhyay to break down the state of the race and stakes for major party leaders as the 2025 election nears the finish line. Finding the funny in news satire when real life is no joke For people who work in the business of political satire and news comedy, there's no shortage of rich source material these days. But misinformation, disinformation and leaders who can seem stranger than fiction are complicating the craft. Chattopadhyay speaks with two veterans of the scene – The Beaverton 's Luke Gordon Field and a founding member of The Onion, Christine Wenc – about the challenges of skewering the news today, and how satire can help people make sense of the absurdity of real life. What the first and last words we speak say about us We may think of them as the most cherished or meaningful words we'll ever speak: Our first words as a baby, and our last words before we die. But as linguist Michael Erard explores in his book Bye Bye, I Love You, the significance of them varies according to culture and history, and their meaning is often supplied more by the listener than the speaker. He tells Chattopadhyay that they are nevertheless truly powerful, marking the beginning and end of our life connecting with others. 50 years ago, the Khmer Rouge began its reign of terror in Cambodia. Justice remains elusive April 17, 1975, marked the start of Year Zero, the attempt by the Khmer Rouge and its leader Pol Pot to "reset" Cambodia and fashion it into a new Communist society by purging swaths of culture, traditions and people. An estimated 1.5 to two million Cambodians were killed and hundreds of thousands fled to other countries, including Canada. The Sunday Magazine senior producer Howard Goldenthal looks at the legacy of that time, and how far we've come in attempts to pursue justice for war crimes since then.
